Term
Hormone that controls maturation of RBC |
|
Definition
|
|
Term
Process of stem cell maturation |
|
Definition
- pluripotent stem cell to unipotential stem cell
- forms proerythroblasts
- it divides four or five times (requires all the machinery for DNA synthesis, without it, there will not be division)
- as they divide, the cell gets smaller
- results in a cell with no subcellular organelles, but still has ribosomes: reticulocytes
- reticulocytes go into circulation, and after 24 hours, mature into RBC
|
|
|
Term
Major protein synthesized during RBC development |
|
Definition
|
|
Term
Rate limiting deoxynucleotide in DNA replication |
|
Definition
|
|
Term
Products formed when carbons in purine rings are oxidized |
|
Definition
- hypoxanthine (one carbon)
- xanthine (two carbons)
- uric acid (all three carbons)
|
|
|
Term
Hypoxanthine is related to what purine? xanthine is related to what purine?
How |
|
Definition
- hypoxanthine relats to adenine (difference of NH2 and double bond O at same C)
- xanthine related to guanosine (difference btw NH2 and double bond O at same C)
|
|
|
Term
how is purine ring synthesized (not whole pathway) |
|
Definition
- via non-oxidative part of HMP shunt produces ribose 5 P (remember, this is fully reversible)
- ribose 5 P and ATP produces PRPP and AMP via PRPP synthetase
- PRPP and Gln produce Glu, PR-1 amine, pyrophosphate via amidotransferase
- committed step, so major conrol point for pathway
- gives one of the N of the ring
- after nine steps, we get end product: inosine monophosphate
|
|
|
Term
Sources of nitrogen in purine synthesis |
|
Definition
|
|
Term
sources of C in purine synthesis |
|
Definition
|
|
Term
|
Definition
- IMP, Asp, and GTP form adenylosuccinate and GTP via adenylosuccinate synthetase
- adenylosuccinate forms fumarate and AMP via adenylosuccinase
GTP is the energy souce and Asp is the energy source.
|
|
|
Term
|
Definition
- IMP and NAD converted to XMP and NADH via IMP dehydrogenase
- XMP, ATP, and Gln form Glu, ADP, and GMP via amidotransfrase
ATP is energy source and Gln is N source |
|
|
Term
Rxn involved in mononucleotide kinases |
|
Definition
- NMP and ATP to NDP and ADP via mononucleotide kinases
Can be AMP kinase, GMP kinase, UMP kinase, CMP kinase, TMP kinase |
|
|
Term
Process of Dinucleotide kinase |
|
Definition
- NDP and ATP form NTP and ADP via dinucleotide kinase
Can be GDP, CDP, UDP, TDP |
|
|
Term
Control of purine synthesis |
|
Definition
- increases in AMP negatively feedback on adenylosuccinase
- increases in GMP negatively feedback on amindotransferases (in major control step, PRPP to PP-1 amine, and syn. step of GMP)
|
|
|
Term
Process of degredation of AMP |
|
Definition
- two options
- AMP to IMP via daminase
- AMP to adenosine via phosphodiesterase
- two options
- IMP to inosine via phosphodiesterase
- adenosine to inosine via deaminase
- inosine to hypoxanthine via purine nucleotide phosphorylase
- hypoxanthine to xanthine via xanthine oxidase (flavoprotein)
- xanthine to uric acid via xanthine oxidase
|
|
|
Term
Clinical application- if you are deficient in deaminase, leading to increased adenosine, what pathology results? |
|
Definition
severe combined immunodeficiency (SCID) |
|
|
Term
Process of Degradation of GMP |
|
Definition
- GMP to guanosine via phosphodiesterase
- guanosine to guanine via purine nucleotide phosphorylase
- guanine to xanthine via deaminase
- xanthine to uric acid via xanthine oxidase (flavoprotein)
|
|
|
Term
|
Definition
- accumulation of uric acid in the body due to overproduction (genetic) or reduced excretion in the kidney
- for some reason, keep making PRPP and keep making AMP and GMP
- the more made, the more that is broken down
- it forms sodium urate, which is not very soluble
- it will form crystals in the joints
- can be triggered by infection, diet, cancer
|
|
|
Term
Salvage pathway enzymes for making purines in mononucleotide forms and their reactions |
|
Definition
- hypoxanthine and PRPP form IMP via hypoxanthine guanine phosphoribosyl tranferase (HGPRT)
- adenosine and PRPP form AMP via adenine phosphoribosyl transferase
- guanine and PRPP form GMP via HGPRT
|
|
|
Term
Symptoms if deficient in HGPRT |
|
Definition
infants will chew on ends of toes, fingers, lips (probably due to role in brain metabolism) |
|
|
Term
Rate limiting step in pyrimidine biosynthesis |
|
Definition
|
|
Term
Process of pyrimidine nucleotide biosynthesis |
|
Definition
- use Gln, CO2, ATP to form ADP and carbamoyl phosphate via CPS II
- CP and Asp form open ring intermediate via Aspartate transcarbamolylase
- major control point (RATE LIMITING)
- via dihydroorotase, form dihydrooratic acid
- dihydrooratic acid and NAD form NADH and oratic acid via dihydroorotate DH
- oratic acid and PRPP form OMP via orotate phosphoribosyltransferase
- OMP forms CO2 and UMP via orotidylate decarboxylase
- UTP, Gln, and ATP form Glu, ADP, and CTP via CTP synthetase
|
|
|
Term
First pyrimidine we have the tendency to form (think of structure) |
|
Definition
uracil (two carbons oxidized) |
|
|
Term
Synthesis of deoxynucleotides in pyrimidine synthesis |
|
Definition
- NDP (N can be A, C, U, G) and thioredoxin (reduced form) form deoxy-NDP and thioredoxin (oxidized form)
- thioredoxin (oxidized form) and NADPH forms NADP and thioredoxin (reduced form)
This is the only way I can get deoxynucleotides. If its defective, it is detremental to life. |
|
|
Term
|
Definition
- dUMP and methylene tetrafolate form dTMP and difolate via thymidylate synthase
- Major target for cancer therapy (if its defective, we cant make thymine for DNA, so stops DNA replication)
- dTMP and ATP form dTDP and ADP via mononucleotide kinase
|
|
|